Blood Coagulation & Fibrinolysis

Papers
(The median citation count of Blood Coagulation & Fibrinolysis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
New approaches to the genetic study of bleeding diathesis in our center: from sanger to next-generation sequencing67
New treatments for primary immune thrombocytopenia21
Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans18
Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays18
Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms13
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe13
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination12
Multiple thrombotic sources and embolic events at arterial sites in a patient with protein-C deficiency11
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy10
Comparing fondaparinux and low molecular weight heparin for thromboprophylaxis after hip and knee arthroplasty: a systematic review and meta-analysis9
An atypical presentation of catastrophic antiphospholipid syndrome with refractoriness to treatment9
Clot waveform analysis in hemophilia carriers9
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding9
Predictive value of miR-24-3p and miR-1277-5p in hemodialysis patients with vascular access thrombosis8
Obesity and physical exercise in hemophilia8
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays8
Time-in-therapeutic range falls as the target international normalized ratio range increases in patients on warfarin8
The physiology of hemostasis7
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome7
A founder effect in hemophilia A patients from Russian Ural region with a new p.(His634Arg) variant in F8 gene7
Disability and the social impact of hemophilia7
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency7
Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab7
The determination of euglobulin clot lysis time reference intervals in Beckton Dickinson and Kima 3.2% sodium citrate coagulation tubes7
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream7
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant6
Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis6
Venous thromboembolism secondary prophylaxis in elderly people (over 75 years old) with low-dose direct oral anticoagulants6
Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease6
CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury6
The procoagulant potential before and after surgery for endometriosis and its association with disease severity6
Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients6
Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus5
Haploidentical stem cell transplantation in DOCK8 deficiency: a case report of successful outcomes5
Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism5
Acquired Bernard–Soulier syndrome and hypodysfibrinogenaemia because of multiple myeloma5
Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population5
Is the combination of two automated rapid assays for diagnosis of heparin-induced thrombocytopenia necessary?5
Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy5
Rare coagulation factor deficiencies: a five-year experience from a single tertiary care center in South India5
Anticoagulant and antiplatelet activity of aqueous extracts of Citrus sinensis and Lippia alba: interactions and potential for the development of antithrombotics5
Why do patients with antiphospholipid syndrome bleed? A clinical paradox5
Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report5
A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency4
Evaluation of a 4 min 4000g centrifugation protocol for routine coagulation assays4
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock4
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations4
Optimizing factor VIII dosing in obese individuals with haemophilia A4
Evaluation of the activated partial thromboplastin time and its influential factors in ischemic heart disease patients under heparin treatment4
Tissue factor-dependent coagulation activation in intracranial neoplasms: a comparative study4
Harmonizing factor assay-related testing performed in a large laboratory network4
Performance evaluation of the Sysmex CN-6000-automated coagulation analyzers for routine coagulation tests4
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis4
Congenital factor V deficiency in Taiwan: identification of a novel variant p.Tyr1813∗ and two variants specific to East Asians4
A rare case of essential thrombocythemia with pseudo-hyperkalemia4
Two patients with protein S deficiency and cerebral venous sinus thrombosis: nonsense mutations of the PROS1 gene may account for these deficiencies4
Analysis of heparin-induced thrombocytopenia diagnostic and management strategies in individuals with inconclusive antibody optical densities3
CRISPR/Cas9 mediated generation of zebrafish f9a mutant as a model for hemophilia B3
Molecular mechanism analysis of a family with hereditary coagulation FXI deficiency caused by compound heterozygous mutations3
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation3
Adrenal insufficiency revealing bilateral adrenal hemorrhage related to JAK2 V617F-positive essential thrombocythemia: about two cases3
Hemolysis detection accuracy on Stago sthemO 3013
Lupus anticoagulant hypoprothrombinemia syndrome with multiple and high-titer antiphospholipid antibodies strongly interfered with coagulation assays3
Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient3
Interpreting coagulation mixing study results in the era of direct oral anticoagulants3
Mannose-binding lectin-associated serine protease-1 cleaves plasminogen and plasma fibronectin: prefers plasminogen over known fibrinogen substrate3
Direct oral anticoagulant neutralization by activated charcoal DOAC-Remove for thrombophilia screening3
The factor V H1327R (rs1800595) polymorphism is associated with venous thromboembolic events: a case–control study in southern Iran3
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment3
The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage3
Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience3
Bleeding disorders in Saudi Arabia, causes and prevalence: a review3
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding3
Hemostatic cover in orthopedic surgery2
Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial2
Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review2
Warfarin versus direct oral anticoagulants in South Asian octogenarians: a retrospective review2
Thrombin generation assay: the present and the future2
A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism2
Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study2
A challenging case of heparin-induced skin necrosis without thrombocytopenia2
Hemorrhagic complications in individuals with liver disease submitted to minor oral surgery2
Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease2
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada2
Measuring coagulopathy in pediatric craniofacial surgery2
Enhancing prediction of thrombosis associated with breast cancer using prechemotherapy hematologic and coagulation characteristics2
Management of autoimmune factor XIII deficiency in a frail, elderly patient2
Psychological complications among patients with congenital bleeding disorders2
Presentation of concurrent thrombotic thrombocytopenic purpura and Graves’ disease2
Serum levels of inflammatory markers, sP-selectin, IL-1β, IL-6, and hsCRP are positively correlated with tissue factor transcript level of peripheral blood mononuclear cells in stroke2
In-vitro thromboelastographic characterization of reconstituted whole blood utilizing cryopreserved platelets2
The role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as venous thromboembolism predictors in breast cancer patients pre- and post-therapy2
Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency2
Clinical and economic implications of false-positive heparin-induced thrombocytopenia immunoassays: utility of the 4T score2
Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates2
Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey2
Evaluation of coagulation parameters and impact of transfusion on coagulation in patients with beta thalassemia major2
Hemostatic parameters predict 90-day mortality in hospitalized cirrhotic patients with acute decompensation: a prospective cohort study2
Disseminated intravascular coagulation in acute leukemia patients2
Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event2
Optimal dosing of bemiparin for deep vein thrombosis treatment in children: a retrospective study2
Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose2
Assessment of clinical characteristics and treatment outcomes of pediatric patients with intracardiac thrombosis: a single-center experience2
Naive haemophilia mice displayed different pattern of cytokine profiles of cytokine profiles changes might be associated with subclinical bleeding2
Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII2
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study2
Sustained good response to rituximab in acquired von Willebrand syndrome2
Acquired factor XIII deficiency and its unprecedented association with multiple myeloma: case report and literature review1
The most common disease-causing mutation of factor XIII deficiency is corrected by CRISPR/CAS9 gene editing system1
Evaluation of paediatric immune thrombocytopenia patients with clinical and laboratory findings: emphasizing the role of monocytosis1
Assessment of coagulation assays on Roche Cobas t711 analyzer: performance and clinical implications1
Evaluation of ISTH-BAT as a predictor for factor deficiency in haemophilia carriers: a single-centre experience1
Severe acquired Factor VII deficiency complicating an aplastic anemia, successfully treated with corticosteroids1
New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants1
Challenges in managing severe homozygous protein c deficiency: a case report1
Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice1
Never too soon to be thinking about heparin-induced thrombocytopenia! A case report of early onset heparin-induced thrombocytopenia1
The impact of neutrophil extracellular traps in coronavirus disease - 2019 pathophysiology1
Self-limited thrombotic thrombocytopenic purpura1
The role of factor XIII in patient blood management1
The evaluation of reactive oxygen species generation and free mitochondrial DNA in platelet concentrates during 5 days of storage1
The role of genetics in the diagnosis and treatment of haemorrhagic diathesis: a historical perspective1
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?1
The predictive role of platelet count for bleeding in patients with hepatitis B virus and hepatitis C virus infection1
Significant difference between coagulation parameters and clinicopathological characteristics in breast cancer1
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen1
Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT1
Noninvasive prenatal diagnosis of congenital factor XIII deficiency in Iran1
Impact of cytochrome P-450 3A4 enzyme/P-glycoprotein inducing antiseizure medications on direct oral anticoagulant therapy1
A retrospective study on the use of low-molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complications1
Evaluation of D-dimer levels measured by different analytical methods in COVID-19 patients1
Management of gastrointestinal bleeding in a patient with type 3 von Willebrand disease and inhibitors to von Willebrand factor: a case report1
New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9 min earlier1
Is dynamic change in mean platelet volume related with composite endpoint development after transcatheter aortic valve replacement?1
Efficacy of extended microthrombolysis in an elderly lady with purpura fulminans1
Association of hemostasis and inflammation biomarkers with outcomes in acute coronary syndromes1
Incidence of factor XII deficiency in critically ill patients with a prolonged activated partial thromboplastin time: a prospective observational study1
Whole blood thrombin generation hypercoagulable profile in a patient with hemolytic crisis due to paroxysmal nocturnal hemoglobinuria: a case report1
Compound heterozygous mutations (p.L68R∗37 and p.T241N) lead to abnormal protein levels and structures in hereditary FVII deficiency1
The impact of vascular endothelial glycocalyx on the pathogenesis and treatment of disseminated intravascular coagulation1
The impact of intrauterine growth on coagulation and factor XII function in preterm infants1
Nonpharmacological treatment for coping with pain1
Prenatal diagnosis for hemophilia A (intron 22 inversion) reveals a rare association with Klinefelter syndrome with diagnostic difficulties in molecular interpretation1
Severe thrombocytopenia associated to bevacizumab in a patient with scleroderma, gastrointestinal angiodysplasias and refractory gastrointestinal bleeding1
Endothelium-biomarkers for postthrombotic syndrome: a case–control study1
Comment on: coagulopathy following Crotaline snakebites in northeast Florida1
Protein S Erlangen: a novel PROS1 gene mutation associated with quantitative protein S deficiency1
Prolonged prothrombin time does not correlate with clinical bleeding symptoms in newly diagnosed paediatric leukaemia patients1
Assessment of risk factors for deep vein thrombosis associated with natural anticoagulants and fibrinolytic regulatory proteins1
The coexistence of antiβ2 glycoprotein 1 antibody antibody has no effect on hemophilia A patient1
In vitro differential inhibition of the factor XI activity assay in the setting of a lupus anticoagulant1
Coagulopathy following Crotaliπae snakebites in northeast Florida1
The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma1
Rotational thromboelastometry for diagnosis of fibrinolysis induced by urokinase in an in-vitro model1
Genetic analysis of compound heterozygous pathogenic variants of the F11 gene in two Chinese patients with hereditary factor XI deficiency1
True vs. false immune-mediated thrombotic thrombocytopenic purpura exacerbations: a clinical case in the caplacizumab era1
Hematological treatment and prophylaxis in patients with and without inhibitors1
Clot waveform analysis in acute promyelocytic leukemia1
Acquired factor V and factor X Deficiency coexisting with acquired dysfibrinogenaemia in a patient with light chain myeloma1
New developments in the diagnosis of primary immune thrombocytopenia1
Hereditary hepatic fibrinogen storage disease with a novel fibrinogen variant FGG c.1113T>A (fibrinogen Seoul III)1
Comparison of bleeding and ischemic events with apixaban vs. rivaroxaban in triple antithrombotic therapy regimens1
Recessively inherited protein C deficiency in two sisters: intracerebral hemorrhage and coagulopathy complications1
4-Factor prothrombin complex concentrates and factor VIII inhibitor bypass activity use in cardiac surgery1
Pharmacokinetics, efficacy and safety of a novel fibrinogen concentrate in pediatric patients with congenital afibrinogenemia1
Homozygous MTHFR C677T carriers develop idiopathic portal vein thrombosis 20 years earlier than wild type1
0.075976133346558